Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03382977
Title Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors VBI Vaccines Inc.
Indications

glioblastoma

Therapies

VBI-1901

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.